Theralase Technologies Inc. V.TLT

Alternate Symbol(s): V.TLT.W | TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc.

Bullboard Posts

Comment by Claridgeon Nov 08, 2019 3:00pm

75 Views

Post# 30329054

RE:RE:RE:RE:RE:Letter to the Editors of Simply Wall St

I agree.

Any serious analyst that would want to have a minimum of credibility would not have writtent an article that way, with such poor structure.

___________________

nemo3 - (11/8/2019 2:13:30 PM)
RE:RE:RE:RE:Letter to the Editors of Simply Wall St

It is a stupid article that totally dismisses what TLT is doing and the great potential this stock has if Ph 2 can replicate the results that patients 5 and 6 had in Ph 1. The article has no real merit.

Bullboard Posts

Rock Tech notches approvals for German lithium refinery